Long Term Renal Function After CRRT in the Paediatric Intensive Care Unit, a Follow-up Study.
1 other identifier
observational
156
1 country
1
Brief Summary
In this study the investigators will evaluate the long-term renal function in children treated with continuous renal replacement therapy (CRRT) due to acute kidney injury (AKI) and multiple organ failure (MOF) in the pediatric intensive care unit (PICU). These children are not always referred for nephrology follow up after their ICU stay and it is unclear to what extent the patients suffer from chronic renal disease. The primary aim is to establish the frequency of chronic kidney disease (CKD) in children treated with CRRT due to AKI. Secondary outcomes will include mortality, frequency of end stage-renal disease (ESRD) and need for hemodialysis and/or renal transplantation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2022
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 20, 2022
CompletedFirst Submitted
Initial submission to the registry
November 7, 2022
CompletedFirst Posted
Study publicly available on registry
November 29, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 12, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 12, 2024
CompletedJuly 31, 2025
April 1, 2024
2.7 years
November 7, 2022
July 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Chronic renal disease (CKD)
Frequency of chronic renal disease (CKD) according to KDIGO definitions at nephrology follow-up.
Up to12 years.
Chronic renal disease (CKD)
Frequency of chronic renal disease according to ICD diagnosis in Swedish National Patient Register.
Up to 12 years
Secondary Outcomes (7)
Hypertension
Up to 12 years
End-stage renal disease
Up to 12 years
Hypertension
Up to 12 years
Dialysis Therapy.
Up to 12 years
Renal transplantation
Up to 12 years
- +2 more secondary outcomes
Study Arms (1)
Children treated with continuous renal replacement therapy in the intensive care unit.
Children treated with CRRT in the ICU due to AKI stage ≥1 (according to KDIGO) and/or ≥2 organ failures. The aim is to evaluate their long term renal function and establish the frequency of chronic kidney disease. Nephrology follow up will be done by a pediatric nephrologist for children living in the Stockholm area or have ongoing care at Karolinska University Hospital. Due to high mortality in this group of patients and the fact that many patients are referred to Karolinska University Hospital from other regions in Sweden, a substantial number of patients will be lost to follow-up. The investigators will therefore conduct a register-based study of all children who received CRRT due to AKI and/or MOF at Karolinska University Hospital from 2008-2021. Data regarding mortality, cause of death and diagnosis of chronic renal disease will be collected from the Swedish National Patient Register and National Cause of Death Register.
Eligibility Criteria
Children treated with CRRT in the intensive care unit.
You may qualify if:
- \- Age newborn to 18 when admitted to ICU. CRRT treatment 2008-2021 due to AKI stage ≥ stage 1 (according to KDIGO) and/or ≥ 2 organ failures
You may not qualify if:
- CRRT due to metabolic and/or endocrinologic comorbidity.
- Chronic renal failure before CRRT.
- Previous renal transplantation.
- Prospective part:
- \- Not a resident of Stockholm County and no planned follow up at Karolinska University Hospital.
- Retrospective part:
- \- Patient referred to Karolinska University Hospital from a hospital outside Sweden.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Region Stockholmlead
Study Sites (1)
Pediatric Perioperative Medicine and Intensive Care
Stockholm, Sweden, 171 76, Sweden
Related Publications (10)
Almarza S, Bialobrzeska K, Casellas MM, Santiago MJ, Lopez-Herce J, Toledo B, Carrillo A. [Long-term outcomes of children treated with continuous renal replacement therapy]. An Pediatr (Barc). 2015 Dec;83(6):404-9. doi: 10.1016/j.anpedi.2014.12.018. Epub 2015 Feb 13. Spanish.
PMID: 25683273BACKGROUNDAndersson A, Norberg A, Broman LM, Martensson J, Flaring U. Fluid balance after continuous renal replacement therapy initiation and outcome in paediatric multiple organ failure. Acta Anaesthesiol Scand. 2019 Sep;63(8):1028-1036. doi: 10.1111/aas.13389. Epub 2019 Jun 3.
PMID: 31157412BACKGROUNDSutherland SM, Zappitelli M, Alexander SR, Chua AN, Brophy PD, Bunchman TE, Hackbarth R, Somers MJ, Baum M, Symons JM, Flores FX, Benfield M, Askenazi D, Chand D, Fortenberry JD, Mahan JD, McBryde K, Blowey D, Goldstein SL. Fluid overload and mortality in children receiving continuous renal replacement therapy: the prospective pediatric continuous renal replacement therapy registry. Am J Kidney Dis. 2010 Feb;55(2):316-25. doi: 10.1053/j.ajkd.2009.10.048. Epub 2009 Dec 30.
PMID: 20042260BACKGROUNDWu L, Zhang P, Yang Y, Jiang H, He Y, Xu C, Yan H, Guo Q, Luo Q, Chen J. Long-term renal and overall survival of critically ill patients with acute renal injury who received continuous renal replacement therapy. Ren Fail. 2017 Nov;39(1):736-744. doi: 10.1080/0886022X.2017.1398667.
PMID: 29199512BACKGROUNDAskenazi DJ, Feig DI, Graham NM, Hui-Stickle S, Goldstein SL. 3-5 year longitudinal follow-up of pediatric patients after acute renal failure. Kidney Int. 2006 Jan;69(1):184-9. doi: 10.1038/sj.ki.5000032.
PMID: 16374442BACKGROUNDHayes LW, Oster RA, Tofil NM, Tolwani AJ. Outcomes of critically ill children requiring continuous renal replacement therapy. J Crit Care. 2009 Sep;24(3):394-400. doi: 10.1016/j.jcrc.2008.12.017. Epub 2009 Mar 27.
PMID: 19327959BACKGROUNDDiane Mok TY, Tseng MH, Chiang MC, Lin JL, Chu SM, Hsu JF, Lien R. Renal replacement therapy in the neonatal intensive care unit. Pediatr Neonatol. 2018 Oct;59(5):474-480. doi: 10.1016/j.pedneo.2017.11.015. Epub 2017 Dec 21.
PMID: 29396136BACKGROUNDMorelli S, Ricci Z, Di Chiara L, Stazi GV, Polito A, Vitale V, Giorni C, Iacoella C, Picardo S. Renal replacement therapy in neonates with congenital heart disease. Contrib Nephrol. 2007;156:428-33. doi: 10.1159/000102134.
PMID: 17464154BACKGROUNDCalderon-Margalit R, Golan E, Twig G, Leiba A, Tzur D, Afek A, Skorecki K, Vivante A. History of Childhood Kidney Disease and Risk of Adult End-Stage Renal Disease. N Engl J Med. 2018 Feb 1;378(5):428-438. doi: 10.1056/NEJMoa1700993.
PMID: 29385364BACKGROUNDMammen C, Al Abbas A, Skippen P, Nadel H, Levine D, Collet JP, Matsell DG. Long-term risk of CKD in children surviving episodes of acute kidney injury in the intensive care unit: a prospective cohort study. Am J Kidney Dis. 2012 Apr;59(4):523-30. doi: 10.1053/j.ajkd.2011.10.048. Epub 2011 Dec 28.
PMID: 22206744BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Urban Fläring
Children Perioperative Medicine & Intensive Care, Karolinska University Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 7, 2022
First Posted
November 29, 2022
Study Start
January 20, 2022
Primary Completion
October 12, 2024
Study Completion
October 12, 2024
Last Updated
July 31, 2025
Record last verified: 2024-04